Porcine Somatostatin Receptor 2 Displays Typical Pharmacological sst2 Features but Unique Dynamics of Homodimerization and Internalization
Authors:
- Mario Durán-PradoMario Durán-Prado
- Christine BucharlesCBChristine Bucharles
- Bruno J. GonzalezBGBruno J. Gonzalez
- Rafael Vázquez-MartínezRVRafael Vázquez-Martínez
- Antonio J. Martínez-FuentesAMAntonio J. Martínez-Fuentes
- Socorro García-NavarroSGSocorro García-Navarro
- Simon J. RhodesSRSimon J. Rhodes
- Hubert VaudryHVHubert Vaudry
- María M. MalagónMMMaría M. Malagón
- Justo P. CastañoJusto P. Castaño
- 1 January 2007
- journal article
- Published by The Endocrine Society in Endocrinology
- Vol. 148 (1) , 411-421
Abstract
Somatostatin (SRIF) exerts its multiple actions, including inhibition of GH secretion and of tumoral growth, through a family of five receptor subtypes (sst1-sst5). We recently reported that an sst2-selective agonist markedly decreases GH release from pig somatotropes, suggesting important roles for this scarcely explored receptor, psst2. Here, functional expression of psst2 in Chinese hamster ovary-K1 and human embryonic kidney-293-AD cell lines was employed to determine its pharmacological features and functional ability to reduce cAMP, and to examine its homodimerization and internalization dynamics in real time in single living cells. Results show that psst2 is a high-affinity receptor (dissociation constant = 0.27 nm) displaying a typical sst2 profile (nm affinity for SRIF-14≥SRIF-28>cortistatin>MK678>octreotide) and high selectivity (EC50 = 1.1 nm) for the sst2 agonist l-779,976, but millimolar or undetectable affinity to other sst-specific agonists (sst3>sst1>sst5⋙sst4). Accordingly, SRIF dose-dependently inhibited forskolin-stimulated cAMP with high potency (EC50 = 6.55 pm) and modest efficacy (maximum 29.1%) via psst2. Cotransfection of human embryonic kidney-293 and Chinese hamster ovary-K1 cells with two receptor constructs modified with distinct fluorescent tags (psst2-YFP/psst2-CFP) enabled fluorescence resonance energy transfer measurement of physical interaction between psst2 receptors and also receptor internalization in single living cells. This revealed that under basal conditions, psst2 forms constitutive homodimers/homomultimers, which dissociate immediately (11 sec) upon SRIF binding. Interestingly, contrary to human sst2, psst2 rapidly reassociates (110.5 sec) during a subsequent process that temporally overlaps with receptor internalization (half-maximal = 95.1 sec). Therefore, psst2 is a potent inhibitory receptor displaying a unique set of interrelated dynamic features of agonist-dependent dimerization, dissociation, internalization, and reassociation, a cascade of events that might be critical for receptor function.Keywords
This publication has 46 references indexed in Scilit:
- Two Discontinuous Segments in the Carboxyl Terminus Are Required for Membrane Targeting of the Rat γ-Aminobutyric Acid Transporter-1 (GAT1)Journal of Biological Chemistry, 2004
- Heterodimerization of Somatostatin and Opioid Receptors Cross-modulates Phosphorylation, Internalization, and DesensitizationJournal of Biological Chemistry, 2002
- β‐Arrestin is involved in the desensitization but not in the internalization of the somatostatin receptor 2A expressed in CHO cellsFEBS Letters, 2002
- A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applicationsNature Biotechnology, 2002
- Protein Kinase C Activation Stimulates the Phosphorylation and Internalization of the sst2A Somatostatin ReceptorJournal of Biological Chemistry, 2000
- Nonpeptidyl Somatostatin Agonists Demonstrate That sst2 and sst5 Inhibit Stimulated Growth Hormone Secretion from Rat Anterior Pituitary CellsBiochemical and Biophysical Research Communications, 1999
- Activation of adenylate cyclase by human recombinant sst5 receptors expressed in CHO‐K1 cells and involvement of Gαs proteinsBritish Journal of Pharmacology, 1999
- Molecular Cloning and Sequencing of Porcine Somatostatin Receptor 2+Biochemical and Biophysical Research Communications, 1994
- The Rat SSTR2 Somatostatin Receptor Subtype Is Coupled to Inhibition of Cyclic AMP AccumulationBiochemical and Biophysical Research Communications, 1993
- Cloning and expression of a novel mouse somatostatin receptor (SSTR2B)FEBS Letters, 1992